Changan Group Unveils Updated “Vast Ocean Plan 2.0” and highlight Next-Generation BlueCore Hybrid at Auto China 2026
Building on Changan Group's long-term "1+4+4+5" strategy, the company is advancing global…
ViewSonic Monitor Achieves EPEAT 2.0 Registration, Marking Early Adoption of Updated Sustainability Criteria
Advancing circular design through evolving sustainability criteriaBREA, Calif., April 23, 2026 /PRNewswire/…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the…
LuminEye Nano-Drops Product Information Updated as Consumer Interest in Eye Health Supplement Options and Vision Support Alternatives Grows in 2026
New York, NY, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Life Line Screening (Updated): What You Need to Know?
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- in 2026, The…
Heal N Soothe (Updated): Does It Work For Chronic Pain?
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- In 2026, Millions…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
Updated IOC report shows 86 per cent of all permanent Olympic venues still in use
23 October 2025 - An updated analysis of venues shows that 86 per…
